Newsletters

08.17.20

340B Action Heats Up: New Developments From the Courts, Administration and Drug Makers

In the courts, in the Administration and in drug maker initiatives, action on the Section 340B prescription drug discount program has heated up this summer.


08.14.20

Transforming Primary Healthcare for Women: The Path Forward

The fragility of the primary healthcare system has become markedly apparent in the wake of the COVID-19 pandemic.


08.11.20

Medicare Telehealth Coverage and Reimbursement After the Public Health Emergency

Over the past five months, Congress and the Centers for Medicare & Medicaid Services (CMS) have dramatically, but temporarily, expanded coverage and reimbursement for telehealth services in response to the COVID-19 pandemic.


08.11.20

President Trump Signs Executive Order to Encourage U.S. Manufacturing of Essential Medications

On August 6, President Trump signed an Executive Order, Ensuring Essential Medicines, Medical Countermeasures, and Critical Inputs Are Made in the United States, designed to reduce U.S. dependency on foreign sources of pharmaceuticals and other medical technologies while, at the same time, reviving ...


08.10.20

Will COVID-19 Nursing Home Tragedies Lead to Real Reform?

The first major COVID-19 outbreak in the United States was in a nursing home in Kirkland, Washington, in late February. 


08.05.20

Transforming Primary Healthcare for Women: A Framework for Addressing Gaps and Barriers

Primary healthcare plays an essential role in effectively addressing women’s unique health needs from puberty to reproduction through menopause and late life.


08.04.20

President Trump Signs Drug Pricing Executive Orders: How Will They Impact Pharma and Providers?

Prescription drug pricing is emerging as one of several healthcare issues that may become a focus of the presidential race as well as contested congressional races this fall.


07.31.20

CMS Approvals of COVID-19 1115 Waivers are Limited to Date

Four months after the Centers for Medicare & Medicaid Services (CMS) offered state Medicaid programs a new COVID-19 Section 1115 waiver opportunity, five of at least 20 applying states have received approval of their waiver applications.


07.27.20

Expanding Behavioral Healthcare Access in MA Through Telehealth: Sustaining Progress Post-Pandemic

Telebehavioral healthcare has the unique ability to improve access to behavioral health services by increasing connectivity between patients and providers of behavioral healthcare resources, decreasing wait times and eliminating logistical barriers.


07.23.20

HHS Issues New COVID-19 Reporting Guidance to Hospitals, Drawing Criticism

On July 10, the Department of Health and Human Services issued new guidance to hospitals regarding reporting COVID-19-related data to the federal government, including data related to COVID-19 testing, hospital occupancy, and supply availability.